Molecular markers in the diagnosis and staging of breast cancer

This publication has 67 references indexed in Scilit:

• Gene expression profiling predicts clinical outcome of breast cancer
  Nature, 2002
• HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization
  Laboratory Investigation, 2001
• Amplification of c-myc by Fluorescence In Situ Hybridization in a Population-Based Breast Cancer Tissue Array
  Laboratory Investigation, 2001
• Cytokeratin 8 Immunostaining Pattern and E-CadherinExpression Distinguish Lobular From Ductal BreastCarcinoma
  American Journal of Clinical Pathology, 2000
• Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
  New England Journal of Medicine, 2000
• Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
  JNCI: Journal of the National Cancer Institute, 1996
• Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
  Annals of Surgery, 1994
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
  Genes & Development, 1994
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
  Science, 1987
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985